ARIA : Analysis & Opinions

  1. Ariad Receives Interest as a Buyout Candidate

    September 22, 2016
    Following failed buyout talks with Baxalta last year, Ariad’s stock is spiking amid rumors of a takeover.
  2. Biotech Stocks: Are They Back?

    June 1, 2016
    The bearish trends over the past year have started to reverse themselves which has benefted the biotech industry
  3. Is Ariad Pharmaceuticals a Buyout Candidate?

    May 29, 2015
    It's amazing what a difference two years can make. Two years ago, Ariad Pharmaceuticals (NASDAQ: ARIA) was flying high on ...
  4. 3 Risks Ariad Investors Ought to Know About

    April 3, 2015
    Ariad Pharmaceuticals (NASDAQ: ARIA) already has one FDA-approved drug on the market, but that doesn't mean it's immune ...
  5. This Biotech Stock Gained 350%. Here's Why There's Still 86% ...

    February 10, 2014
    What a way to start 2014! Gloom and doom have struck the stock market with a roughly 1,000-point decline in the Dow Jones ...
Trading Center